Detalhe da pesquisa
1.
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
Lancet
; 390(10103): 1654-1663, 2017 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28756902
2.
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Gynecol Oncol
; 147(2): 243-249, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807367
3.
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Gynecol Oncol
; 143(3): 511-515, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27692669
4.
Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis.
Gynecol Oncol
; 143(2): 294-301, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27542967
5.
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation.
Gynecol Oncol
; 135(2): 208-12, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25152438
6.
Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer.
FASEB J
; 26(8): 3306-20, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22767227
7.
Gynecologic oncology group strategies to improve timeliness of publication.
Clin Trials
; 10(4): 617-23, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23794406
8.
Cytokine use and survival in the first-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.
Gynecol Oncol
; 127(3): 495-501, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23000389
9.
Identification of the optimal pathway to reach an accurate diagnosis in the absence of an early detection strategy for ovarian cancer.
Gynecol Oncol
; 127(3): 564-8, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22940492
10.
State of the science in ovarian cancer quality of life research: a systematic review.
Int J Gynecol Cancer
; 22(7): 1273-80, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22872168
11.
Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Gynecol Oncol
; 121(3): 542-5, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21420157
12.
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.
Int J Gynecol Cancer
; 21(4): 763-70, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21543938
13.
Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study.
Gynecol Oncol
; 117(2): 270-5, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20181381
14.
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.
Gynecol Oncol
; 118(2): 139-44, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20452658
15.
Posttherapy residual disease associates with long-term survival after chemoradiation for bulky stage 1B cervical carcinoma: a Gynecologic Oncology Group study.
Am J Obstet Gynecol
; 203(4): 351.e1-8, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20541170
16.
Gynecologic Oncology Group quality assurance audits: analysis and initiatives for improvement.
Clin Trials
; 7(4): 390-9, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20576671
17.
Node count and groin recurrence in early vulvar cancer: A Gynecologic Oncology Group study.
Gynecol Oncol
; 113(1): 52-6, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19193428
18.
Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
Gynecol Oncol
; 114(2): 346-52, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19411096
19.
Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial.
Am J Obstet Gynecol
; 197(5): 503.e1-6, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17980189
20.
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
J Clin Oncol
; 21(15): 2849-55, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12885800